However, from end May (three months after Wegovys removal from the FDA drug shortage list) the compounding pharmacies will no longer be allowed to sell Wegovy (Novo will take all the regulatory measures to prevent compounding pharmacies from selling the drug)
& Nunez, G
Lancet Diabetes Endocrinol 7(7):549559 Mok J et al (2023) Safety and efficacy of liraglutide, 3.0 mg, once daily vs placebo in patients with poor weight loss following metabolic surgery: the BARI-OPTIMISE randomized clinical trial
doi: 10.1016/j.heliyon.2022.e08799 15
A Comparison of Weight Loss Medications: Topiramate, Bupropion, Naltrexone, Phentermine, and GLP1s by Dimitri Gitelmaker, MD As a physician board certified in obesity management, I understand the importance of evidence-based information when it comes to prescribing medications for weight loss
These new GLP-1RA medications suggest a tremendous and potentially life-changing opportunity for patients